ASQUAN acquired by COSMOGEN
Context
This transaction represents Cosmogen's first external growth initiative since its spin-off and is a transformative step to double its operational scale. Driven by its controlling shareholder, Weinberg Capital Partners, the acquisition aims to create a new global reference in the premium beauty packaging market, the Cosmogen & Asquan Group. The strategic rationale is founded on the strong complementarities between the two entities. Cosmogen contributes its deep expertise in patented, technical applicators and its established relationships with major European beauty conglomerates. Asquan provides a broad, multi-category product portfolio, a significant foothold in the dynamic U.S. market through its work with independent brands, and well-regarded operational processes. This merger creates a more resilient and diversified group with an expanded product catalog, a balanced geographic footprint, and a wider client portfolio. The deal is a direct response to the consolidation trend within the wider cosmetics industry, giving the combined entity the critical size required to serve global brands more effectively and enhance its competitive positioning. The integration process is reinforced by the founder of Asquan joining the new group's leadership as Chief Operating Officer.
ASQUAN, which reported an EBITDA margin of in 2025, is valued in this transaction at an EV/EBITDA multiple of , a level to compare with the average currently observed in the Industry & Manufacturing sector (11.6x).
-> Deep-dive in Industry & Manufacturing market trends
Target
Asquan is a specialist in providing premium, multi-category packaging solutions for the beauty industry. The company has built a prominent reputation through its broad offering of custom-designed products, catering to the diverse needs of cosmetic brands. Asquan has a particularly strong presence in the United States, where it collaborates extensively with dynamic and fast-growing independent brands, often referred to as "indie brands." This focus allows the company to remain agile and responsive to emerging market trends. The company is also recognized for the quality of its organizational structure and efficient operational processes, which ensure reliable execution for its clients. It operates on a "fabless" model, focusing on design and project management while outsourcing manufacturing. In 2025, Asquan's dedication to sustainable and ethical practices was recognized with an EcoVadis Gold medal, underscoring its strong performance in environmental, social, and governance (ESG) criteria. The firm's core expertise lies in creating innovative and high-quality packaging that helps brands connect with their consumers.
Ent. Value
Equity Value
Multiples
EV / Revenue
EV / EBITDA
EV / EBIT
Historical Financials (EUR)
Similar deals in Chemicals & Materials
| Date | Acquirer | Target | Country | Sector |
|---|---|---|---|---|
| 06/2026 | HOWDENS | DIY KITCHENS | UNITED KINGDOM | Building & Interior Materials |
| 06/2026 | JOHNSON MATTHEY | CORMETECH | UNITED STATES | Specialty Chemicals |
| 05/2026 | STERIMED | SIMAGEC | FRANCE | Packaging & Containers |
| 05/2026 | SAICA GROUP | THIMM GROUP | GERMANY | Paper & Cardboard |
| 04/2026 | LIFCO | METALLTECH | ITALY | Construction Materials |
| 04/2026 | INTERNATIONAL PAPER COMPANY | NORPAC | UNITED STATES | Paper |
| 02/2026 | MEARTHANE PRODUCTS CORPORATION | AXILLON AEROSPACE - POLYURETHANE | UNITED STATES | Plastics |
| 02/2026 | SAGARD | ESSENCES & PARFUMS | FRANCE | Flavors & Fragrances |
| 02/2026 | STRATUS PACKAGING | FREPPEL IMPRIMEUR | FRANCE | Labels & Adhesives |
| 02/2026 | CVC | DSM-FIRMENICH ANH (ANIMAL NUTRITION & HEALTH) | SWITZERLAND | Nutrition |
REFERENCES
Revenue range: 10M - 30M EUR
Note: This page provides detailed data on a private equity M&A transaction. Detailed and exact financial metrics for the acquisition of ASQUAN by COSMOGEN are reserved for mynth community members. Register for free to unlock full data.
Authors: This transaction was contributed by a verified mynth contributor and cross-checked against available transaction documents and official company communications.
Target: asquan
Acquirer: cosmogen